Vildagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4), an enzyme that degrades glucagon-like-peptide 1 (GLP-1), and has been used to rescue insulin resistance in pancreatic β-cells with lipid overload (54). The gene discussed is DPP4; the disease is Insulin resistance.